CELUW
Celularity Inc. NASDAQ$0.01
Mkt Cap $248,346
52w Low $0.01
10.4% of range
52w High $0.03
50d MA $0.01
200d MA $0.03
P/E (TTM)
0.0x
EV/EBITDA
-1.5x
P/B
—
Debt/Equity
-1.8x
ROE
322.8%
P/FCF
-2.1x
RSI (14)
—
ATR (14)
—
Beta
0.70
50d MA
$0.01
200d MA
$0.03
Avg Volume
13.0K
About
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I clinical tri…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2026 | AMC | -1.50 | -0.85 | +43.3% | 0.01 | -12.6% | +13.8% | -12.6% | -11.5% | -10.3% | -9.2% | +3.4% | — |
| Nov 14, 2025 | AMC | -1.50 | -0.88 | +41.6% | 0.02 | +11.8% | +11.8% | +42.2% | +32.7% | -12.6% | +37.2% | +7.0% | — |
| Aug 29, 2025 | AMC | — | -1.02 | — | 0.06 | +0.0% | +0.0% | -31.7% | -8.3% | -8.7% | -16.8% | -41.5% | — |
| Jun 30, 2023 | AMC | — | -0.00 | — | 0.06 | +7.3% | +6.3% | +22.2% | -11.0% | -6.3% | -12.7% | -15.0% | — |
| Mar 31, 2023 | AMC | — | -0.00 | — | 0.06 | -1.7% | +4.2% | +8.3% | +16.7% | +16.7% | +16.7% | +3.3% | — |
| Dec 31, 2022 | AMC | — | — | — | — | — | — | — | — | — | — | — | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 29 | HC Wainwright & Co. | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| Jan 29 | Morgan Stanley | Downgrade | Equal Weight → Underweight | — | — | — | — | — | — | — | — | — |
| Dec 21 | Oppenheimer | Downgrade | Outperform → Perform | — | $0.12 | $0.10 | -16.7% | +2.1% | -32.8% | -25.0% | -25.0% | -39.0% |
| Sep 11 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | — | — | — | — | — | — | — | — |
| Aug 22 | Truist | Maintains | Hold → Hold | — | $0.40 | $0.43 | +7.4% | +7.4% | -14.6% | +0.0% | -15.0% | -13.8% |
| Apr 5 | Truist | Downgrade | Buy → Hold | — | $1.29 | $1.29 | +0.0% | +3.9% | +0.8% | -0.8% | -1.6% | +6.2% |
Data updated apr 28, 2026 4:49am
· Source: massive.com